Cargando…
Follistatin N terminus differentially regulates muscle size and fat in vivo
Delivery of follistatin (FST) represents a promising strategy for both muscular dystrophies and diabetes, as FST is a robust antagonist of myostatin and activin, which are critical regulators of skeletal muscle and adipose tissues. FST is a multi-domain protein, and deciphering the function of diffe...
Autores principales: | Zheng, Hui, Qiao, Chunping, Tang, Ruhang, Li, Jianbin, Bulaklak, Karen, Huang, Zhenhua, Zhao, Chunxia, Dai, Yi, Li, Juan, Xiao, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628274/ https://www.ncbi.nlm.nih.gov/pubmed/28912572 http://dx.doi.org/10.1038/emm.2017.135 |
Ejemplares similares
-
MicroRNA-206 Downregulation Improves Therapeutic Gene Expression and Motor Function in mdx Mice
por: Bulaklak, Karen, et al.
Publicado: (2018) -
Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet–induced obesity
por: Tang, Ruhang, et al.
Publicado: (2020) -
Systemic administration of Follistatin288 increases muscle mass and reduces fat accumulation in mice
por: Gangopadhyay, Samudra S.
Publicado: (2013) -
A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice
por: Jin, Quan, et al.
Publicado: (2019) -
Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
por: Qiao, Chunping, et al.
Publicado: (2018)